Articles tagged "Kidney transplantation"

2020 American Transplant Congress
Barriers to Organ Transplantation among Underrepresented Racial and Ethnic Groups
M. Parra
Duke Clinical Research Institute, Durham, NC
*Purpose: To understand how known patient, provider, and system-level barriers to organ transplantation differ by race and ethnicity.*Methods: We searched Pubmed and Scopus for articles…
2020 American Transplant Congress
A Novel Formula to Determine Optimal Immunosuppression in Renal Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: Towards Individualized Immunosuppression
O. Pankewycz¹, M. Laftavi¹, E. Onan², D. Rucker¹, D. Wang¹, K. Bhuta¹, R. Gruessner³, A. Gruessner³
¹SUNY, Upstate Medical University, Syracuse, NY, ²Cukurova University, Adana, Turkey, ³SUNY, Downstate Medical University, New York, NY
*Purpose: Tacrolimus (TAC) and mycophenolic acid (MPA) remain the most commonly used drug combination for kidney transplant immunosuppression. Adequate drug dosing is challenging due to…
2020 American Transplant Congress
Machine Learning Improves Kidney Discard Predictability
M. Barah¹, S. Mehrotra²
¹IEMS Department, Northwestern University, Evanston, IL, ²IEMS Department, MEAS, Northwestern University, Evanston, IL
*Purpose: Despite the shortage of kidneys supply, 18%-20% of deceased donor kidneys are discarded annually.*Methods: The cohort consisted of adult deceased donor kidneys donated between…
2020 American Transplant Congress
Long-Term Effect of Kidney Transplantation on Peripheral Arterial Disease
C. Choi¹, M. Ahn¹, S. Kim¹, A. Han², H. Ohe³, S. Min², S. Ahn², S. Min², J. Ha²
¹Transplantation and Vascular Surgery, Chungnam National University Hospital, Daejeon, Korea, Republic of, ²Transplantation and Vascular Surgery, Seoul National University Hospital, Seoul, Korea, Republic of, ³Transplantation and Vascular Surgery, Inje University College of Medicine, Seoul, Korea, Republic of
*Purpose: Peripheral arterial disease (PAD) that needs treatment is common and major complication in patients with chronic kidney disease (CKD). Most surgeons have been using…
2020 American Transplant Congress
Long-Term Outcomes in Recipients of Allografts from Living Kidney Donors with Hypertension
F. Al Ammary¹, S. Yu², A. Muzaale², L. Luckmini², D. C. Crews¹, D. Brennan¹, D. Segev², A. B. Massie²
¹Medicine, Johns Hopkins, Baltimore, MD, ²Surgery, Johns Hopkins, Baltimore, MD
*Purpose: Allografts from living kidney donors may “carry” subclinical pathological abnormalities to the recipient and thus lead to adverse clinical outcomes. Because one mechanism underlying…
2020 American Transplant Congress
Effectiveness and Tolerability of Cidofovir for the Management of BK Viremia in Kidney Transplant Recipients
M. Thornberg¹, J. Hedvat¹, N. Lange¹, C. Brennan², D. Salerno¹, D. Tsapepas²
¹NewYork-Presbyterian Hospital, Department of Pharmacy, New York, NY, ²Columbia Irving University Medical Center, Department of Transplant Surgery, New York, NY
*Purpose: BK viremia (BKV) is a common complication after kidney transplantation (KT) that often leads to graft dysfunction and loss. Without consensus management guidelines and…
2020 American Transplant Congress
Managing the Road to Kidney Transplantation in the Elderly
R. S. Munjal, K. Kalra, A. Cherukuri, D. Jorgensen, S. Verma, P. Sood, R. Mehta, C. Puttarajappa, S. Hariharan, C. Wu
Nephrology, UPMC, Pittsburgh, PA
*Purpose: We hypothesize that careful patient selection and waitlist management minimizes the impact of advanced recipient age on kidney transplant outcomes.*Methods: A total of 3,521…
2020 American Transplant Congress
Evaluating Postoperative Opioid Requirements of Kidney Transplant Recipients
M. A. Muir¹, K. R. Szempruch², R. E. Dupuis¹, A. H. Toledo³, P. Serrano Rodriguez³
¹Pharmacotherapy and Experimental Therapeutics, UNC Eshleman School of Pharmacy, Chapel Hill, NC, ²Pharmacy, UNC Medical Center, Chapel Hill, NC, ³Surgery - Transplant, UNC Medical Center, Chapel Hill, NC
*Purpose: Multimodal analgesia with non-opioid analgesics in the setting of enhanced recovery after surgery (ERAS) pathway has proven beneficial in managing pain and decreasing adverse…
2020 American Transplant Congress
Organ Offer Behavioral Research Enhances Transplant Surgeon Training
T. S. Diwan¹, D. Stewart², K. Lindblad², A. Dick³, R. Hirose⁴, L. Ratner⁵
¹Univ of Cincinnati Med Ctr, Cincinnati, OH, ²United Network for Organ Sharing, Richmond, VA, ³Seattle Children's Hospital, Seattle, WA, ⁴UCSF Health, San Francisco, CA, ⁵Columbia Univ/NY Pres Hosp, New York, NY
*Purpose: Due to the complexities of fielding organ offers, the 2019 ASTS 2nd Year Surgical Fellows Symposium’s agenda included multiple sessions devoted to training on…
2020 American Transplant Congress
A Mouse Model of Non-MHC Mismatches Recapitulates Chronic Allograft Dysfunction and I-IFTA
V. Pavlov¹, F. Garzon¹, R. Haroon Al Rasheed², K. Banu¹, F. ElSalem¹, L. Li¹, E. Cody¹, M. Planoutene¹, N. Chun¹, Z. Zhang¹, J. Leventhal¹, B. Murphy¹, P. Heeger¹, M. C. Menon¹
¹Medicine, Mount Sinai School of Medicine, New York, NY, ²Pathology, Mount Sinai School of Medicine, New York, NY
*Purpose: Fibrotic and atrophic changes or IF/TA is an important cause of graft loss. We reported that genome-wide donor-recipient non-HLA mismatches independently correlate with Banff…